Eliem Therapeutics Stock Forecast - Daily Balance Of Power
| ELYMDelisted Stock | USD 3.09 0.06 1.90% |
Eliem Stock Forecast is based on your current time horizon.
Eliem |
| Previous Daily Balance Of Power | Daily Balance Of Power | Trend |
| (0.53) | 1.0 |
| Check Eliem Therapeutics Volatility | Backtest Eliem Therapeutics | Trend Details |
Eliem Therapeutics Trading Date Momentum
| On July 11 2024 Eliem Therapeutics was traded for 7.07 at the closing time. The top price for the day was 7.43 and the lowest listed price was 6.98 . The trading volume for the day was 126.1 K. The trading history from July 11, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 1.39% . The overall trading delta against the current closing price is 0.42% . |
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare Eliem Therapeutics to competition
View Eliem Therapeutics Related Equities
| Risk & Return | Correlation |
Eliem Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Eliem Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eliem Therapeutics shares will generate the highest return on investment. By undertsting and applying Eliem Therapeutics stock market strength indicators, traders can identify Eliem Therapeutics entry and exit signals to maximize returns.
Eliem Therapeutics Risk Indicators
The analysis of Eliem Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Eliem Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting eliem stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.62 | |||
| Standard Deviation | 4.81 | |||
| Variance | 23.13 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in Eliem Stock
If you are still planning to invest in Eliem Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eliem Therapeutics' history and understand the potential risks before investing.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |